Abstracts Archive

Introduction:Peripheral T-cell lymphomas (PTCLs) are rare, heterogeneous hematological disorders with poor outcomes under standard therapies. In 2019, Ukraine launched a prospective national lymphoma registry to collect real-world data on subtypes to better understand clinical features, treatment ef...

Introduction Large cell transformation (LCT) in mycosis fungoides/Sézary syndrome (MF/SS) portends poor survival, yet specific risk factors and real-world disparities in outcomes remain incompletely defined. Objective  In a large retrospective cohort of ...

We assessed the overall survival (OS) impact of time-to-relapse (TTR) in R/R nodal-mature-T-cell-lymphomas (nMTCL) in multinational cohorts with validation using observational and randomized independent cohorts. Patients with 1L CR were assigned to TTR12 (< 12m) or without TTR12 based on time-to-pro...

Introduction:T-cell lymphomas (TCL) are a heterogenous group of aggressive lymphoid malignancies associated with limited therapeutic options and poor patient outcomes. Real-world barriers to treatment access remain poorly described, yet understanding these is vital for improving care equity.Objectiv...

Introduction: R/R PTCL has poor outcomes and no uniform salvage standard. Epigenetic agent–containing regimens (Epi-Rx), used as mono- or combination therapy, are increasingly employed. Objectives/Methods: This meta-analysis was conducted to compare the efficacy of Epi-Rx against conventional...

Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a rare, aggressive T-cell neoplasm linked to chronic HTLV-1 infection. In non-endemic regions like the U.S., affected patients are primarily of Afro-Caribbean and Hispanic descent. Real-world data on treatment outcomes remain limited.Methods:&nb...